Contract Research & SMO conducting and supporting clinical trials of study drugs and medical devices
Total Trials
9
As Lead Sponsor
8
As Collaborator
1
Total Enrollment
1,103
NCT01836757
Effect of Methyl-Sulphonyl-Methane on Osteoarthritis and Cartilage
Phase: Phase 1
Role: Lead Sponsor
Start: Sep 30, 2012
Completion: Oct 31, 2013
NCT02597062
High-Dose Weekly Carfilzomib Plus Cyclophosphamide and Dexamethasone in the Treatment of Relapsed Multiple Myeloma
Phase: Phase 2
Role: Collaborator
Start: Jul 5, 2016
Completion: Feb 1, 2022
NCT03215524
A Study Of Daratumumab, Low-Dose Oral Dexamethasone and Cyclophosphamide With Or Without Pomalidomide
Start: Oct 25, 2017
Completion: Jun 24, 2022
NCT03715478
Multi-Center Study of GSK2857916 in Combination With Pomalidomide and Dex
Phase: Phase 1/2
Start: Nov 26, 2018
Completion: Dec 31, 2026
NCT03697629
A Study of an Accelerated Infusion Rate of Daratumumab in Patients With Relapsed and Refractory Multiple Myeloma
Start: Dec 3, 2018
Completion: Dec 20, 2021
NCT03588845
The Small Intestine Bacterial Overgrowth Study Pilot
Phase: N/A
Start: Feb 15, 2019
Completion: Sep 1, 2021
NCT04258683
A Study of Pembrolizumab Added to the Standard First-Line Therapy of Cyclophosphamide, Bortezomib, and Dexamethasone (CyBorD) for NDMM NTE
Start: Feb 17, 2021
Completion: Oct 31, 2022
NCT04786028
A Study of Isatuximab Added to Standard CyBorD Induction and Lenalidomide Maintenance Treatments in ND-TEMM
Start: Dec 8, 2021
Completion: Jun 30, 2027
NCT05272826
Study of Iberdomide, Bortezomib, Dexamethasone With Isatuximab Added on Demand for ND-NTE MM Patients
Start: Dec 12, 2024
Completion: Mar 31, 2031
Loading map...